Inventor · disambiguated record
Mark Vincent
Also filed as: VINCENT MARK · VINCENT MARK D · VINCENT MARK DAVID
3 granted patents·13 pending applications·4 citations·filing 2002–2024
54Inventor score
Files withSARISSA INC6VINCENT MARK2VINCENT MARK DAVID2CADUCEUS INFORMATION SYSTEMS I1KOROPATNICK DONALD JAMES1
Top patents by PatentIndex Score
16 records- 0178US9359605B2Method of treating cancer by inhibition of DNA repair proteinsVINCENT MARK·Filed 2012·Granted Jun 7, 2016·4 cites·12 claims
- 0257US2025179501A1Methods of treating cancer and/or enhancing sensitivity to cancer treatment by increasing tumor mutation burden or tumor indelsVINCENT MARK DAVID·Filed 2024·Application pending·0 cites
- 0356US2010144660A1Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer thereapyYM BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 0454US2008318891A1Antisense oligonucleotides against thymidylate synthaseKOROPATNICK DONALD JAMES·Filed 2007·Application pending·0 cites
- 0554US2004248986A1Use of n,n-diethyl-2-{-4-(phenylmethyl) - phenoxy} ethanamine monohydrochloride (dppe) in cancer therapyFiled 2002·Application pending·0 cites
- 0651US2010204920A1System for development of individualised treatment regimensCADUCEUS INFORMATION SYSTEMS I·Filed 2006·Application pending·0 cites
- 0748US2006089322A1Antisense oligonucleotides for identifying drug targets and enhancing cancer therapiesVINCENT MARK·Filed 2003·Application pending·0 cites
- 0841US2024083883A1Rad51 binding inhibitors and methods of use thereofSARISSA INC·Filed 2021·Application pending·0 cites
- 0941US2005272683A1Antisense oligonucleotides against thymidylate synthaseSARISSA INC·Filed 2005·Application pending·0 cites
- 1037US10907159B2Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapiesSARISSA INC·Filed 2016·Granted Feb 2, 2021·0 cites·17 claims
- 1137US2017016002A1Method of Treating Cancer by Inhibition of DNA Repair ProteinsSARISSA INC·Filed 2016·Application pending·0 cites
- 1234US2006135450A1Combinations of antisense oligonucleotides directed against thymidylate synthase mrna and uses thereofSARISSA INC·Filed 2003·Application pending·0 cites
- 1332US12234459B2Methods of treating cancer and/or enhancing sensitivity to cancer treatment by increasing tumor mutation burden or tumor indelsVINCENT MARK DAVID·Filed 2018·Granted Feb 25, 2025·0 cites·8 claims
- 1432US2008255066A1Antisense oligonucleotide strategies for the enhancement of cancer therapiesSARISSA INC·Filed 2008·Application pending·0 cites
- 1530US2005119263A1Treatment of breast cancerFiled 2002·Application pending·0 cites
- 1629US2011003879A1Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereofVINCENT MARK D·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Vincent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →